Search clinical trials for: FOLFIRI Bevacizumab chemotherapy

Total 14698 results

Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaborators

Terminated

Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer (ABCDE)

Breast Cancer

United States
AIO-Studien-gGmbH
Celgene

Terminated

A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy (PANTHEON)

Metastatic Pancreatic Ductal Adenocarcinoma

Germany
UNICANCER

Completed

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Colorectal Cancer

France
UNICANCER

Completed

Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network (SULTAN)

Colorectal Cancer Metastatic

France
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC

Non-Small Cell Lung Cancer

United States
Cedars-Sinai Medical Center

Completed

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Glioma | Glioblastoma | Astrocytoma | Brain Tumor | Glioblastoma Multiforme

United States
SCRI Development Innovations, LLC
Eli Lilly and Company; Genentech, Inc.

Terminated

Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

Lung Cancer

United States
Centre Oscar Lambret
Sanofi

Terminated

Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR). (PULSAR)

Metastatic Colorectal Cancer

France
Vall d'Hebron Institute of Oncology
European Organisation for Research and Treatment of Cancer - EORTC

Terminated

Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer

Chemotherapy | ColoRectal Cancer | MSI | Resistance, APC

Belgium, Netherlands, Spain, Italy
Institut Bergonié
Novartis; Aventis Pharmaceuticals; Sanofi-Synthelabo

Completed

Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (CEPAFIRI)

Gastric Cancer

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1)

Metastatic Colorectal Cancer

United Kingdom, Spain, Germany, Poland, Australia, Belgium, Brazil, Denmark, France, Italy, Netherlands, Russian Federation
Hoffmann-La Roche

Completed

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower150)

Carcinoma, Non-Small-Cell Lung

United States, Spain, France, Belgium, Australia, Germany, Argentina, Japan, Brazil, Italy, Singapore, Russian Federation, Taiwan, Netherlands, Peru, Chile, Latvia, Ukraine, Mexico, Lithuania, Slovakia, Bulgaria, Portugal, Austria, Swit... and more
Yale University
National Cancer Institute (NCI); Northwestern University

Completed

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Liver Cancer

United States
Duke University
Johns Hopkins University; Genentech, Inc.

Completed

Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer (AdORN)

Ovarian Neoplasms | Ovarian Cancer

United States
Nordic Society of Gynaecological Oncology - Clinical...

Withdrawn

Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Ovarian Cancer

Norway, Denmark, Finland
Grupo Espanol Multidisciplinario del Cancer Digestivo

Completed

Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab (POSIBA)

Colorectal Cancer

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo
Amgen; Pivotal S.L.

Active, not recruiting

Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal (BEYOND)

Colorectal Cancer Metastatic

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo
Amgen; Pivotal S.L.

Completed

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status (OPALO)

Neoplasm Metastasis | Colorectal Neoplasms | Colorectal Cancer Metastatic | Colorectal Carcinoma

Spain
Federation Francophone de Cancerologie Digestive

Completed

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

France
Eli Lilly and Company
Genentech, Inc.

Completed

Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy

Non-small Cell Lung Cancer

United States
National Taiwan University Hospital

Active, not recruiting

Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases (A-Plus)

Breast Cancer | Brain Metastases

Taiwan
National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditions

United States
University of Chicago
Genentech, Inc.

Completed

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

United States
University Hospital, Rouen

Unknown

VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer (VASCATAQ)

Oncology

France
ImmunityBio, Inc.

Withdrawn

QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy

Melanoma
ImmunityBio, Inc.

Withdrawn

QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Head and Neck Squamous Cell Carcinoma
ImmunityBio, Inc.

Withdrawn

QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

Triple Negative Breast Cancer
ImmunityBio, Inc.

Withdrawn

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Urothelial Carcinoma
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
UNICANCER

Completed

Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) (BEVABEL)

Collecting Duct Carcinoma (Kidney)

France
Fujian Cancer Hospital

Withdrawn

Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

China
UNICANCER

Completed

Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

France
Abramson Cancer Center of the University of Pennsylvania

Completed

A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Amgen

Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Sarcoma | Lymphoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Metastatic Cancer | Solid Tumors | Carcinoid | Locally Advanced

United States, Spain, Poland
UNICANCER
Federation Francophone de Cancerologie Digestive

Completed

Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer

Colorectal Cancer

France
UNICANCER

Completed

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

France
AbbVie

Terminated

A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

Cancer

United States, Belgium, Canada, Korea, Republic of, Spain, Taiwan
Sun Yat-sen University

Withdrawn

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Metastatic Cancer | ICC

China
National Cancer Institute, Naples

Completed

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer (BRANCH)

Rectal Cancer
Peking University Cancer Hospital & Institute
Zhejiang Cancer Hospital; West China Hospital; The First Affiliated Hospital... and other collaborators

Completed

Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis (PARECEC)

Metastasis | Colorectal Cancer Stage IV

China
Chang Gung Memorial Hospital
Hoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology...

Completed

Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer

Epithelial Ovarian Cancer

Taiwan
AryoGen Pharmed Co.

Completed

Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Iran, Islamic Republic of
Henan Cancer Hospital

Completed

Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer

Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Colorectal Cancer | Metastatic Cancer

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma

Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
Federation Francophone de Cancerologie Digestive

Completed

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

France
Hoffmann-La Roche

Completed

An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

Neoplasms

Brazil, Estonia, France, Italy, Spain, Sweden, Germany, United Kingdom, Korea, Republic of, Romania, Czechia, Russian Federation, Canada, Mexico, South Africa, Turkey, Bulgaria, Slovakia, Austria, Netherlands, Hungary
Cliniques universitaires Saint-Luc- Université...
Grand Hôpital de Charleroi

Completed

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. (BEV-ONCO2012)

Metastatic Colorectal Cancer

Belgium
University of Texas Southwestern Medical Center
University of Chicago; Columbia University; Duke University

Completed

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

Mesothelioma

United States
Genentech, Inc.

Completed

A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

Cancer

United States

3

Subscribe